HansBiomed Gross Profit vs. Total Debt
| 042520 Stock | KRW 7,420 420.00 6.00% |
For HansBiomed profitability analysis, we use financial ratios and fundamental drivers that measure the ability of HansBiomed to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well HansBiomed utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between HansBiomed's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of HansBiomed over time as well as its relative position and ranking within its peers.
HansBiomed |
HansBiomed Total Debt vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining HansBiomed's current stock value. Our valuation model uses many indicators to compare HansBiomed value to that of its competitors to determine the firm's financial worth. HansBiomed is number one stock in gross profit category among its peers. It also is the top company in total debt category among its peers making up about 0.05 of Total Debt per Gross Profit. The ratio of Gross Profit to Total Debt for HansBiomed is roughly 21.71 . Comparative valuation analysis is a catch-all model that can be used if you cannot value HansBiomed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for HansBiomed's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.HansBiomed Total Debt vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
HansBiomed |
| = | 29.23 B |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
HansBiomed |
| = | 1.35 B |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
HansBiomed Total Debt vs Competition
HansBiomed is the top company in total debt category among its peers. Total debt of Health Care industry is presently estimated at about 298.62 Trillion. HansBiomed adds roughly 1.35 Billion in total debt claiming only tiny portion of equities under Health Care industry.
HansBiomed Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in HansBiomed, profitability is also one of the essential criteria for including it into their portfolios because, without profit, HansBiomed will eventually generate negative long term returns. The profitability progress is the general direction of HansBiomed's change in net profit over the period of time. It can combine multiple indicators of HansBiomed, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. HansBiomed Corporation was founded in 1993 and is based in Seoul, South Korea. HANS BIOMED is traded on Korean Securities Dealers Automated Quotations in South Korea.
HansBiomed Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on HansBiomed. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of HansBiomed position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the HansBiomed's important profitability drivers and their relationship over time.
Use HansBiomed in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if HansBiomed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HansBiomed will appreciate offsetting losses from the drop in the long position's value.HansBiomed Pair Trading
HansBiomed Pair Trading Analysis
The ability to find closely correlated positions to HansBiomed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace HansBiomed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back HansBiomed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling HansBiomed to buy it.
The correlation of HansBiomed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as HansBiomed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if HansBiomed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for HansBiomed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your HansBiomed position
In addition to having HansBiomed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Information Technology ETFs Thematic Idea Now
Information Technology ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Information Technology ETFs theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Information Technology ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in HansBiomed Stock
To fully project HansBiomed's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of HansBiomed at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include HansBiomed's income statement, its balance sheet, and the statement of cash flows.